In this work, we identified that AP-1, in the setting of loss of RRM1 activity, downregulates the level of the c-Myc oncogene, which promotes tumorigenesis in Ewing sarcoma tumors via multiple pathways (42, 43, 46, 47). This evidence concerns the gene FOS and Ewing sarcoma.